Pentoxifylline Enhances Cancer Treatment with Radiation
Author Information
Author(s): Bohm Lothar
Primary Institution: Department of Pharmacology, University of Pretoria
Hypothesis
Pentoxifylline can enhance the effectiveness of radiation therapy by inhibiting homologous recombination repair in tumor cells.
Conclusion
Pentoxifylline improves tumor oxygenation and enhances the toxicity of chemotherapy drugs when used in conjunction with radiation therapy.
Supporting Evidence
- Pentoxifylline enhances radiotoxicity by factors of 1.2 to 2.0 in various tumor cell lines.
- The drug inhibits homologous recombination repair, particularly in G2 phase cells.
- In combination with low doses of cisplatin, Pentoxifylline can lead to toxicity enhancements up to 80 times.
Takeaway
Pentoxifylline helps make cancer treatments like radiation and chemotherapy work better by stopping cancer cells from fixing themselves after being damaged.
Methodology
The study involved in vitro experiments measuring the effects of Pentoxifylline on tumor cell survival and DNA repair mechanisms after irradiation.
Limitations
The clinical benefits of Pentoxifylline in combination with radiation therapy have been modest and not yet fully realized.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website